Trial intelligence / Profile preview

Tecovirimat for mpox or smallpox in Japan

jRCTs031220169Completed

Sponsor
Health and Labour Sciences Research Grants
Start
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of tecovirimat in mpox and smallpox (2 arms), sponsored by Health and Labour Sciences Research Grants. Started Jul 2022; status: completed.

02

Drugs

tecovirimat
03

Conditions

mpoxsmallpox

Beyond the preview

Go deeper on jRCTs031220169.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031220169.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call